Fibroblast growth factor 23: are we ready to use it in clinical practice?
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Fibroblast growth factor 23: are we ready to use it in clinical practice?
Authors
Keywords
-
Journal
JOURNAL OF NEPHROLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-03-04
DOI
10.1007/s40620-020-00715-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial
- (2019) Joachim H. Ix et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Pre-analytical stability of FGF23 with the contemporary immunoassays
- (2019) Niek F. Dirks et al. CLINICA CHIMICA ACTA
- Single Measurements of Carboxy-Terminal Fibroblast Growth Factor 23 and Clinical Risk Prediction of Adverse Outcomes in CKD
- (2019) Daniel Edmonston et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Fibroblast Growth Factor-23 and Risks of Cardiovascular and Noncardiovascular Diseases: A Meta-Analysis
- (2018) Amarnath Marthi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development
- (2018) Natalia Nowak et al. KIDNEY INTERNATIONAL
- Cardiac hypertrophy elevates serum levels of fibroblast growth factor 23
- (2018) Isao Matsui et al. KIDNEY INTERNATIONAL
- The elevation of circulating fibroblast growth factor 23 without kidney disease does not increase cardiovascular disease risk
- (2018) Eva-Maria Pastor-Arroyo et al. KIDNEY INTERNATIONAL
- Biochemical Comparison of 8-hour Haemodialysis and 4-hour Haemodiafiltration, and Two Dialysis Membranes, in a Randomised Cross-over Trial
- (2018) Shi Z. Choo et al. NEPHROLOGY
- Greater fluid overload and lower interdialytic weight gain are independently associated with mortality in a large international hemodialysis population
- (2018) Manfred Hecking et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- OUP accepted manuscript
- (2018) NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease–mineral bone disorder parameters in dialysis patients
- (2018) Markus Ketteler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Burosumab Therapy in Children with X-Linked Hypophosphatemia
- (2018) Thomas O. Carpenter et al. NEW ENGLAND JOURNAL OF MEDICINE
- Technical and diagnostic performance of a new fully automated immunoassay for the determination of intact fibroblast growth factor 23 (FGF23)
- (2018) Josef van Helden et al. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
- Acetate-free biofiltration to remove fibroblast growth factor 23 in hemodialysis patients: a pilot study
- (2017) Valeria Cernaro et al. JOURNAL OF NEPHROLOGY
- Longitudinal FGF23 Trajectories and Mortality in Patients with CKD
- (2017) Tamara Isakova et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Inflammation and elevated levels of fibroblast growth factor 23 are independent risk factors for death in chronic kidney disease
- (2017) Jair Munoz Mendoza et al. KIDNEY INTERNATIONAL
- Effect of lanthanum carbonate on coronary artery calcification and bone mineral density in maintenance hemodialysis patients with diabetes complicated with adynamic bone disease
- (2017) Chunhua Zhang et al. MEDICINE
- Vitamin D treatment attenuates cardiac FGF23/FGFR4 signaling and hypertrophy in uremic rats
- (2017) Maren Leifheit-Nestler et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Addition of Novel Biomarkers for Predicting All-Cause and Cardiovascular Mortality in Prevalent Hemodialysis Patients
- (2017) Kazuomi Yamashita et al. THERAPEUTIC APHERESIS AND DIALYSIS
- Effects of Phosphate Binder Therapy on Vascular Stiffness in Early-Stage Chronic Kidney Disease
- (2017) Michael E. Seifert et al. AMERICAN JOURNAL OF NEPHROLOGY
- FGF23/FGFR4-mediated left ventricular hypertrophy is reversible
- (2017) Alexander Grabner et al. Scientific Reports
- Effects of lanthanum carbonate and calcium carbonate on fibroblast growth factor 23 and hepcidin levels in chronic hemodialysis patients
- (2016) Yu-Ming Chang et al. Clinical and Experimental Nephrology
- Patients with FGF23-related hypophosphatemic rickets/osteomalacia do not present with left ventricular hypertrophy
- (2016) Yuichi Takashi et al. ENDOCRINE RESEARCH
- Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study
- (2016) Nao Souma et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF-23 and Osteoprotegerin but not Fetuin-A are associated with death and enhance risk prediction in non-dialysis chronic kidney disease stages 3-5.
- (2016) Helen V Alderson et al. NEPHROLOGY
- Stability and degradation of fibroblast growth factor 23 (FGF23): the effect of time and temperature and assay type
- (2016) D. El-Maouche et al. OSTEOPOROSIS INTERNATIONAL
- Race, Mineral Homeostasis and Mortality in Patients with End-Stage Renal Disease on Dialysis
- (2015) Julia J. Scialla et al. AMERICAN JOURNAL OF NEPHROLOGY
- Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue
- (2015) Rik Mencke et al. CARDIOVASCULAR RESEARCH
- Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy
- (2015) Alexander Grabner et al. Cell Metabolism
- Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in HemodialysisCLINICAL PERSPECTIVE
- (2015) Sharon M. Moe et al. CIRCULATION
- Experimental Myocardial Infarction Upregulates Circulating Fibroblast Growth Factor-23
- (2015) Olena Andrukhova et al. JOURNAL OF BONE AND MINERAL RESEARCH
- The failing heart is a major source of circulating FGF23 via oncostatin M receptor activation
- (2015) Manfred Richter et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Low Vitamin D and High Fibroblast Growth Factor 23 Serum Levels Associate with Infectious and Cardiac Deaths in the HEMO Study
- (2015) M. Chonchol et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 correlates with volume status in haemodialysis patients and is not reduced by haemodialysis
- (2015) Jelmer K. Humalda et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Risk of Incident Stroke in Community-Living Adults
- (2015) Bhupesh Panwar et al. STROKE
- Hypophosphatemic Rickets: Lessons from Disrupted FGF23 Control of Phosphorus Homeostasis
- (2015) Bracha K. Goldsweig et al. Current Osteoporosis Reports
- Left Ventricular Mass Progression despite Stable Blood Pressure and Kidney Function in Stage 3 Chronic Kidney Disease
- (2014) Michael E. Seifert et al. AMERICAN JOURNAL OF NEPHROLOGY
- FGF23 directly impairs endothelium-dependent vasorelaxation by increasing superoxide levels and reducing nitric oxide bioavailability
- (2014) Neerupma Silswal et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
- (2014) Vincent M. Brandenburg et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor-23 and Cardiovascular Disease in the General Population
- (2014) Bryan Kestenbaum et al. Circulation-Heart Failure
- Dietary phosphorus restriction by a standard low-protein diet decreased serum fibroblast growth factor 23 levels in patients with early and advanced stage chronic kidney disease
- (2014) Shunsuke Goto et al. Clinical and Experimental Nephrology
- The Use of Fibroblast Growth Factor 23 Testing in Patients with Kidney Disease
- (2014) E. R. Smith Clinical Journal of the American Society of Nephrology
- Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
- (2014) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study
- (2014) Romina di Giuseppe et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Fibroblast growth factor 23 and risk of all-cause mortality and cardiovascular events: A meta-analysis of prospective cohort studies
- (2014) Yunjun Xiao et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
- (2014) Jacob A. Udell et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Competitive Interaction Between Fibroblast Growth Factor 23 And Asymmetric Dimethylarginine in Patients With CKD
- (2014) G. Tripepi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mortality Prediction Using Modern Peptide Biomarkers in Hemodialysis Patients - A Comparative Analysis
- (2014) Ferruh Artunc et al. KIDNEY & BLOOD PRESSURE RESEARCH
- Treatment of established left ventricular hypertrophy with fibroblast growth factor receptor blockade in an animal model of CKD
- (2014) G. S. Di Marco et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Plasma FGF23 and the risk of stroke: The Northern Manhattan Study (NOMAS)
- (2014) C. B. Wright et al. NEUROLOGY
- Prognostic Value and Link to Atrial Fibrillation of Soluble Klotho and FGF23 in Hemodialysis Patients
- (2014) Albina Nowak et al. PLoS One
- Fibroblast Growth Factor‐23 and Incident Coronary Heart Disease, Heart Failure, and Cardiovascular Mortality: The Atherosclerosis Risk In Communities Study
- (2014) Pamela L. Lutsey et al. Journal of the American Heart Association
- Variability of New Bone Mineral Metabolism Markers in Patients Treated with Maintenance Hemodialysis: Implications for Clinical Decision Making
- (2013) Etienne Cavalier et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
- (2013) Benjamin D. Parker ANNALS OF INTERNAL MEDICINE
- Fibroblast growth factor 23, left ventricular mass, and left ventricular hypertrophy in community-dwelling older adults
- (2013) Anna Jovanovich et al. ATHEROSCLEROSIS
- Method-specific differences in plasma fibroblast growth factor 23 measurement using four commercial ELISAs
- (2013) Edward R. Smith et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Single FGF-23 Measurement and Time-Averaged Plasma Phosphate Levels in Hemodialysis Patients
- (2013) S. Seiler et al. Clinical Journal of the American Society of Nephrology
- Effects of Dietary Phosphate Restriction and Phosphate Binders on FGF23 Levels in CKD
- (2013) T. Isakova et al. Clinical Journal of the American Society of Nephrology
- Fibroblast Growth Factor 23 and Cardiovascular Mortality after Kidney Transplantation
- (2013) L. C. Baia et al. Clinical Journal of the American Society of Nephrology
- FGF23 concentrations measured using “intact” assays similar but not interchangeable
- (2013) Manish D. Sinha et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Relationship between serum fibroblast growth factor-23 level and mortality in chronic hemodialysis patients
- (2013) Himiko Sugimoto et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Plasma Fibroblast Growth Factor 23, Parathyroid Hormone, 25-Hydroxyvitamin D3, and Risk of Heart Failure: A Prospective, Case-Cohort Study
- (2013) Romina di Giuseppe et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Fibroblast Growth Factor-23 and Cardiovascular Events in CKD
- (2013) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiovascular Effects of Sevelamer in Stage 3 CKD
- (2013) C. D. Chue et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is not associated with and does not induce arterial calcification
- (2013) Julia J. Scialla et al. KIDNEY INTERNATIONAL
- Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency
- (2013) Rika Jimbo et al. KIDNEY INTERNATIONAL
- A protective role for FGF-23 in local defence against disrupted arterial wall integrity?
- (2013) Dongxing Zhu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Biomarkers of inflammation, fibrosis, cardiac stretch and injury predict death but not renal replacement therapy at 1 year in a Canadian chronic kidney disease cohort
- (2013) Adeera Levin et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Time-averaged level of fibroblast growth factor-23 and clinical events in chronic kidney disease
- (2013) Annet Bouma-de Krijger et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease
- (2013) Christin Spatz et al. NEPHRON CLINICAL PRACTICE
- Arterial Klotho Expression and FGF23 Effects on Vascular Calcification and Function
- (2013) Karolina Lindberg et al. PLoS One
- Pan-FGFR Inhibition Leads to Blockade of FGF23 Signaling, Soft Tissue Mineralization, and Cardiovascular Dysfunction
- (2013) Gina M. Yanochko et al. TOXICOLOGICAL SCIENCES
- Fibroblast growth factor 23, mineral metabolism and mortality among elderly men (Swedish MrOs)
- (2013) Per-Anton Westerberg et al. BMC Nephrology
- Fibroblast growth factor 23
- (2013) Edward R Smith et al. ANNALS OF CLINICAL BIOCHEMISTRY
- FGF23 adds value to risk prediction in patients with chronic kidney disease
- (2012) Edward R. Smith et al. BONE
- Intact fibroblast growth factor 23 levels predict incident cardiovascular event before but not after the start of dialysis
- (2012) Chikako Nakano et al. BONE
- Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
- (2012) Kenneth Lim et al. CIRCULATION
- Acute Effects of Very-Low-Protein Diet on FGF23 Levels: A Randomized Study
- (2012) B. Di Iorio et al. Clinical Journal of the American Society of Nephrology
- Effects of Sevelamer on HbA1c, Inflammation, and Advanced Glycation End Products in Diabetic Kidney Disease
- (2012) H. Vlassara et al. Clinical Journal of the American Society of Nephrology
- Biological Variability of Plasma Intact and C-Terminal FGF23 Measurements
- (2012) Edward R. Smith et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- FGF23 neutralization improves chronic kidney disease–associated hyperparathyroidism yet increases mortality
- (2012) Victoria Shalhoub et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF-23 removal is improved by on-line high-efficiency hemodiafiltration compared to conventional high flux hemodialysis
- (2012) Laure Patrier et al. JOURNAL OF NEPHROLOGY
- Fibroblast Growth Factor-23 and Death, Heart Failure, and Cardiovascular Events in Community-Living Individuals
- (2012) Joachim H. Ix et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Phosphate Binders in Moderate CKD
- (2012) G. A. Block et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mineral Metabolites and CKD Progression in African Americans
- (2012) J. J. Scialla et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community
- (2012) Johan Ärnlöv et al. KIDNEY INTERNATIONAL
- Responsiveness of FGF-23 and mineral metabolism to altered dietary phosphate intake in chronic kidney disease (CKD): results of a randomized trial
- (2012) Mhairi Sigrist et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effect of Cinacalcet on Cardiovascular Disease in Patients Undergoing Dialysis
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- Fibroblast growth factor 23 and parathyroid hormone after treatment with active vitamin D and sevelamer carbonate in patients with chronic kidney disease stage 3b, a randomized crossover trial
- (2012) Inger H Bleskestad et al. BMC Nephrology
- Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial
- (2011) Mahmut Ilker Yilmaz et al. AMERICAN JOURNAL OF KIDNEY DISEASES
- Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
- (2011) Tamara Isakova JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- FGF23 induces left ventricular hypertrophy
- (2011) Christian Faul et al. JOURNAL OF CLINICAL INVESTIGATION
- FGF-23 Associates with Death, Cardiovascular Events, and Initiation of Chronic Dialysis
- (2011) J. Kendrick et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
- (2011) Tamara Isakova et al. KIDNEY INTERNATIONAL
- Lanthanum carbonate reduces FGF23 in chronic kidney disease Stage 3 patients
- (2011) E. Gonzalez-Parra et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Cinacalcet treatment and serum FGF23 levels in haemodialysis patients with secondary hyperparathyroidism
- (2011) M. Koizumi et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Effects of Dietary Phosphate and Calcium Intake on Fibroblast Growth Factor-23
- (2010) M. G. Vervloet et al. Clinical Journal of the American Society of Nephrology
- FGF-23 as a Predictor of Renal Outcome in Diabetic Nephropathy
- (2010) S. M. Titan et al. Clinical Journal of the American Society of Nephrology
- Vegetarian Compared with Meat Dietary Protein Source and Phosphorus Homeostasis in Chronic Kidney Disease
- (2010) S. M. Moe et al. Clinical Journal of the American Society of Nephrology
- FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease
- (2010) Mahmut I. Yilmaz et al. KIDNEY INTERNATIONAL
- Serum fibroblast growth factor-23 (FGF-23) levels are independently associated with left ventricular mass and myocardial performance index in maintenance haemodialysis patients
- (2010) A. Kirkpantur et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study
- (2010) V. M. Brandenburg et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease
- (2010) T. Isakova et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Relation between serum fibroblast growth factor-23 level and mortality in incident dialysis patients: are gender and cardiovascular disease confounding the relationship?
- (2010) H. Olauson et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation
- (2010) Wacharee Seeherunvong et al. PEDIATRIC TRANSPLANTATION
- Fibroblast Growth Factor 23: A Possible Cause of Left Ventricular Hypertrophy in Hemodialysis Patients
- (2009) Heng Jung Hsu et al. AMERICAN JOURNAL OF THE MEDICAL SCIENCES
- Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
- (2009) Majd A.I. Mirza et al. ATHEROSCLEROSIS
- Fibroblast Growth Factor 23 and Left Ventricular Hypertrophy in Chronic Kidney Disease
- (2009) Orlando M. Gutiérrez et al. CIRCULATION
- Effects of Cinacalcet and Concurrent Low-Dose Vitamin D on FGF23 Levels in ESRD
- (2009) J. B. Wetmore et al. Clinical Journal of the American Society of Nephrology
- Early Control of PTH and FGF23 in Normophosphatemic CKD Patients: A New Target in CKD-MBD Therapy?
- (2009) R. B. Oliveira et al. Clinical Journal of the American Society of Nephrology
- Initial FGF23-Mediated Signaling Occurs in the Distal Convoluted Tubule
- (2009) E. G. Farrow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
- (2009) G. Jean et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast growth factor-23 and early decrements in kidney function: the Heart and Soul Study
- (2009) J. H. Ix et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
- (2009) R. Goetz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Determination of fibroblast growth factor 23
- (2009) A. C Heijboer et al. ANNALS OF CLINICAL BIOCHEMISTRY
- In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23) -mediated regulation of systemic phosphate homeostasis
- (2008) Teruyo Nakatani et al. FASEB JOURNAL
- Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease
- (2008) A. Covic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Fibroblast Growth Factor 23 and Mortality among Patients Undergoing Hemodialysis
- (2008) Orlando M. Gutiérrez et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited hypophosphatemic disorders in children and the evolving mechanisms of phosphate regulation
- (2008) Murat Bastepe et al. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation